Abstract:Dendritic cells (DCs) play pivotal roles in T-cell homeostasis and activation, and metabolic programing has been recently linked to DC development and function. However, the metabolic underpinnings corresponding to distinct DC functions remain largely unresolved. Here, we demonstrate a special metabolic-epigenetic coupling mechanism orchestrated by tuberous sclerosis complex subunit 1 (TSC1)-mechanistic target of rapamycin (mTOR) for homeostatic DC function. Specific ablation of Tsc1 in the DC compartment (Tsc1DC-KO) largely preserved DC development but led to pronounced reduction in naïve and memory-phenotype cluster of differentiation (CD)8+ T cells, a defect fully rescued by concomitant ablation of mTor or regulatory associated protein of MTOR, complex 1 (Rptor) in DCs. Moreover, Tsc1DC-KO mice were unable to launch efficient antigen-specific CD8+ T effector responses required for containing Listeria monocytogenes and B16 melanomas. Mechanistically, our data suggest that the steady-state DCs tend to tune down de novo fatty acid synthesis and divert acetyl-coenzyme A (acetyl-CoA) for histone acetylation, a process critically controlled by TSC1-mTOR. Correspondingly, TSC1 deficiency elevated acetyl-CoA carboxylase 1 (ACC1) expression and fatty acid synthesis, leading to impaired epigenetic imprinting on selective genes such as major histocompatibility complex (MHC)-I and interleukin (IL)-7. Remarkably, tempering ACC1 activity was able to divert cytosolic acetyl-CoA for histone acetylation and restore the gene expression program compromised by TSC1 deficiency. Taken together, our results uncover a crucial role for TSC1-mTOR in metabolic programing of the homeostatic DCs for T-cell homeostasis and implicate metabolic-coupled epigenetic imprinting as a paradigm for DC specification.

The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity

Regulation of Pdc Fate Determination by Histone Deacetylase 3

Histone deacetylase 11 is an epigenetic regulator of cytotoxic T-lymphocyte effector function and memory formation (P1404)

T Cells Lacking Hdac11 Have Increased Effector Functions And Mediate Enhanced Alloreactivity In A Murine Model

Histone deacetylase function in CD4+ T cells

Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine Tumors

HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment

HDAC11 Regulates Expression of C/EBPβ and Immunosuppressive Molecules in Myeloid-Derived Suppressor Cells.

Histone Deacetylase 11 (HDAC11) is a Regulatory Checkpoint of T-Cell Function: Implications for T-Cell Adoptive Immunotherapy

HDAC1 controls the generation and maintenance of effector-like CD8 T cells during chronic viral infection

The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors

A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs.

HDAC3 Maintains Peripheral T Cell Homeostasis by Refraining From AICD

Transcriptional programming mediated by the histone demethylase KDM5C regulates dendritic cell population heterogeneity and function

Intracellular HSP70L1 inhibits human dendritic cell maturation by promoting suppressive H3K27me3 and H2AK119Ub1 histone modifications

Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity.

TSC1-mTOR-controlled Metabolic Epigenetic Crosstalk Underlies DC Control of CD8+T Cell Homeostasis

Histone Deacetylases 1/2 As Critical Factors in Protein Synthesis and Tumorigenesis

HDAC1: a promising target for cancer treatment: insights from a thorough analysis of tumor functions

Transcriptional control of dendritic cell development and functions

HDAC-mediated Deacetylation of NF-κB is Critical for Schwann Cell Myelination